90 related articles for article (PubMed ID: 21133729)
1. Paraneoplastic peripheral blood eosinophilia in relapsed follicular lymphoma.
Okosun J; McNamara C
Leuk Lymphoma; 2011 Feb; 52(2):328-30. PubMed ID: 21133729
[No Abstract] [Full Text] [Related]
2. Paraneoplastic pemphigus occurring after bendamustine and rituximab therapy for relapsed follicular lymphoma.
Higo T; Miyagaki T; Nakamura F; Shinohara A; Asano H; Abe H; Senda N; Yoshizaki A; Fukayama M; Kurokawa M
Ann Hematol; 2015 Apr; 94(4):683-5. PubMed ID: 25199505
[No Abstract] [Full Text] [Related]
3. Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus.
Kikuchi T; Mori T; Shimizu T; Koda Y; Abe R; Kurihara Y; Funakoshi T; Yamagami J; Sato H; Tsunoda K; Amagai M; Okamoto S
Ann Hematol; 2017 Jul; 96(7):1221-1222. PubMed ID: 28447163
[No Abstract] [Full Text] [Related]
4. Management of relapsed/refractory follicular lymphoma.
Martin P
Clin Adv Hematol Oncol; 2018 Apr; 16 Suppl 10(4):1-12. PubMed ID: 29851937
[No Abstract] [Full Text] [Related]
5. Rethinking Prognosis and Therapy for Follicular Lymphoma.
Jacobson CA; Freedman AS
J Clin Oncol; 2015 Aug; 33(23):2489-91. PubMed ID: 26169620
[No Abstract] [Full Text] [Related]
6. Paraneoplastic pemphigus in a patient with non-Hodgkin's lymphoma.
Plumb R; Doolittle GC
Am J Hematol; 1996 May; 52(1):58-9. PubMed ID: 8638613
[TBL] [Abstract][Full Text] [Related]
7. Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials.
Smith SM; Pitcher BN; Jung SH; Bartlett NL; Wagner-Johnston N; Park SI; Richards KL; Cashen AF; Jaslowski A; Smith SE; Cheson BD; Hsi E; Leonard JP
Lancet Haematol; 2017 Apr; 4(4):e176-e182. PubMed ID: 28314699
[TBL] [Abstract][Full Text] [Related]
8. Case of paraneoplastic pemphigus with follicular lymphoma treated with rituximab.
Aoi J; Makino K; Sakai K; Masuguchi S; Fukushima S; Jinnin M; Inoue Y; Koga H; Hashimoto T; Ihn H
J Dermatol; 2013 Apr; 40(4):285-6. PubMed ID: 23398274
[No Abstract] [Full Text] [Related]
9. Is there a role for bortezomib combinations in the management of patients with follicular lymphoma?
Salles G
J Clin Oncol; 2011 Sep; 29(25):3349-50. PubMed ID: 21810690
[No Abstract] [Full Text] [Related]
10. [How I treat relapsed/transformed follicular lymphoma].
Xu B; Lin ZJ
Zhonghua Xue Ye Xue Za Zhi; 2023 Dec; 44(12):983-988. PubMed ID: 38503520
[No Abstract] [Full Text] [Related]
11. Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis.
Lerch K; Meyer AH; Stroux A; Hirt C; Keller U; Viardot A; Marks R; Schreiber S; Pezzutto A; Scholz CW
Ann Hematol; 2015 Jun; 94(6):981-8. PubMed ID: 25645656
[TBL] [Abstract][Full Text] [Related]
12. Achievement of the longest survival of paraneoplastic pemphigus with bronchiolitis obliterans associated with follicular lymphoma using R-CHOP chemotherapy.
Lee S; Yamauchi T; Ishii N; Hashimoto T; Kinoshita K; Imamura S; Kamiya K
Int J Hematol; 2017 Dec; 106(6):852-859. PubMed ID: 28791608
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic pemphigus occurs most commonly in indolent B cell lymphoma.
Morikawa K; Tsuji T; Yamasaki H; Egashira S; Kaguchi A; Kido M; Tsuda H
Acta Haematol; 2014; 132(1):73-4. PubMed ID: 24481059
[No Abstract] [Full Text] [Related]
14. Successful treatment of recurrent follicular B-cell lymphoma with clarithromycin, prednisolone, and cyclophosphamide.
Ohe M; Hashino S
Korean J Intern Med; 2013 May; 28(3):377-9. PubMed ID: 23682236
[No Abstract] [Full Text] [Related]
15. Prognostic impact of CD38 expression in relapsed or refractory diffuse large B-cell lymphoma and follicular lymphoma transformation.
Wada F; Shimomura Y; Kamijo K; Yamashita D; Ohno A; Himeno M; Maruoka H; Hara S; Ishikawa T
Leuk Lymphoma; 2022 Jun; 63(6):1484-1487. PubMed ID: 35045767
[No Abstract] [Full Text] [Related]
16. Randomized controlled trials in relapsed/refractory follicular lymphoma: a systematic review and meta-analysis.
Police RL; Trask PC; Wang J; Olivares R; Khan S; Abbe A; Colosia A; Njue A; Sherril B; Ruiz-Soto R; Kaye JA; Hamadani M
J Oncol Pharm Pract; 2016 Oct; 22(5):666-78. PubMed ID: 26320127
[TBL] [Abstract][Full Text] [Related]
17. Role of endosonography in rectal lymphoma.
Gavioli M; Bagni A; Garoia C; Piccagli I; Biscardi A; Natalini G
Haematologica; 2000 Aug; 85(8):882-3. PubMed ID: 10942946
[No Abstract] [Full Text] [Related]
18. A skin rash and what lies beneath: paraneoplastic pemphigus, an atypical presentation of follicular cell lymphoma.
Moustafa MA; Seningen JL; Jouni H; Singh PP; el-Azhary RA; Witzig TE
Am J Hematol; 2013 Sep; 88(9):822-3. PubMed ID: 23658142
[No Abstract] [Full Text] [Related]
19. Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL.
Heizmann M; Itin P; Wernli M; Borradori L; Bargetzi MJ
Am J Hematol; 2001 Feb; 66(2):142-4. PubMed ID: 11421295
[TBL] [Abstract][Full Text] [Related]
20. [Follicular lymphoma with paraneoplastic autoimmune multiorgan syndrome].
Hidalgo I; Martinez F; Grau C; Gil I; Azón A
Actas Dermosifiliogr; 2012 Apr; 103(3):244-6. PubMed ID: 21943876
[No Abstract] [Full Text] [Related]
[Next] [New Search]